![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1321, 2002-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adjuvant chemotherapy beneficial in pancreatic cancer?
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemotherapy for all younger women with breast cancer?
Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anastrozole of global value in early breast cancer?
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :